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Picture 2 Sclerodactyly
On laboratory examination, we found elevated 
erythrocyte sedimentation rate (ESR) at 50 mm/
hr and leukocytes count of 12.700/mm3. Her 
urinalysis resulted in elevated protein level at 75 
mg/dL. She also had elevated thyroxine (T4) at 
27.1 mcg/dL (normal limit: 4.5 – 10.9) and TSHs 
at 0.09 mU/L (0.35 – 5.5). She was positive for 
ANA and Anti-Scl-70, but her IgG and IgM 
anticardiolipin antibody (ACA) were negative. Her 
echocardiography, esophagogram (picture 3), and 
chest x-ray (picture 4) were normal. An ultrasound 
on her thyroid revealed diffuse enlargement 
with hypoechoic thyroid lobes associated with 
heterogenous parenchymal appearance.
Picture 3 Barium esophagogram revealed normal 
esophageal motility (no esophageal dilatation)
An abdominal ultrasound showed a fetus in her 
uterus with estimated fetal weight of 1100 grams. It 
was inconsistent with her history of menstruation, 
because the pregnancy would have been about 
31-32 weeks. Her fi nal diagnosis was systemic 
sclerosis with hyperthyroidism, pregnancy, and 
intrauterine growth retardation (IUGR). Her 
Systemic sclerosis (SSc) is a connective tissue 
disease affecting women of childbearing age at 
least fi ve times more than men. For a long time, 
pregnant women with SSc have high morbidity 
and mortality based on case reports and case series. 
Therefore, the disease was a contraindication for 
pregnancy. However, current retrospective studies 
show that despite of an increased frequency of 
prematurity and small for gestational age infants, 
overall maternal and neonatal survival is good. 
With close monitoring and appropriate therapy, 




A 38-year-old woman was referred from Kupang, 
East Nusa Tenggara to rheumatology outpatient 
clinic because of thickened skin, chronic dry 
cough, palpitation, and intermittent diffi culty 
in swallowing since 2 years before admission. 
She had been diagnosed with scleroderma and 
hyperthyroid. Her medications in Kupang were 
methylprednisolone 4 mg b.i.d., propylthiouracil 
100 mg b.i.d., propranolol 10 mg t.i.d., and 
amlodipine 5 mg daily. She had been married 
for 5 years without any history of contraception 
and pregnancy. Her vital signs were normal. Her 
pulse rate was 92 beats/min and regular. She had 
hyperpigmentation and thickening on almost 
all of her skin. There were also salt and pepper 
leukoderma (picture 1) and sclerodactyly (picture 
2). Her abdomen was slightly distended and she 
had Raynaud’s phenomenon.
Picture 1 Salt and pepper leukoderma
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methylprednisolone dosage was changed into once daily in 
the morning and her propranolol was stopped. She was also 
consulted to an obstetrician. It was later decided that she was 
pregnant for 27-28 weeks based on her USG result.
A month later, the patient came with chief complaint of 
palpitation, diarrhea, and prolonged cough. She was admitted 
and observed for the possibility of a thyroid crisis. Her vital 
signs showed blood pressure at 120/ 80 mmHg, heart rate at 
122 beats/ minute, respiration rate at 20 times/ minute, and 
temperature at 36.8 0C. She had normal CBC, renal function 
test, ECG, and stool examination. Her ESR was at 40 mm/
hr and her albumin level was at 2.5 mg/dL. She had elevated 
thyroxine (T4) at >30 mcg/dL and TSHs at 0.741 mU/L. Her 
Burch Wartovsky score was 35 (22–44 means impending 
thyroid crisis). Supportive therapy was given and her 
conditions improved. She also had monitoring of fetal heart 
beat every 6 hours and fetomaternal ultrasonography weekly.
Two weeks later, the patient had a fever, cough, and 
shortness of breath. There were crackles in both lower lobes 
of her lungs. Her leukocytes count was 12.300/ mm3 and her 
chest X ray showed honeycomb appearance in lower lobes of 
her lung. She was diagnosed with pneumonia but interstitial 
lung disease was thought of as a differential diagnosis. 
Antibiotic was given for a week. Her conditions improved, 
but there was a worsening of fetal’s non-stress test (NST) and 
she needed caesarean section. She gave birth to a 1300 grams 
baby boy with length of 36 cm and Apgar Score 8/9. Five days 
later, she was discharged from the hospital. The therapy was 
continued with additional azathioprine 50 mg b.i.d. 
Ten days after, the patient was admitted again due to 
fever and shortness of breath. Her blood pressure was 100/60 
mmHg, pulse rate was 92 beats/minute, respiration rate was 
28 times/minute, and temperature was 38 0C. Her surgery scar 
was in good condition. There were crackles in both lower 
lobes of the lung and her chest x-ray result was the same as 
before. The laboratory result came back with anemia (8.6 g/
dL), low albumin (2.3 mg/dL), normal leukocyte count (9,260/
mm3) normal platelet count (233,000/mm3), and elevated ESR 
(55 mm/hr). Again the patient was diagnosed with pneumonia 
and interstitial lung disease as differential diagnosis. Sputum, 
urine, and blood culture were performed. She was also 
scheduled for chest high resolution CT scan and pulmonary 
function test. While waiting for results, she had oxygen 8 L/
min, intravenous levofl oxacin 750 mg daily, and nebulizer.
A week later, the fever subsided, but her cough and dyspnea 
worsened. The sputum, urine, and blood culture were all 
negative. She was then given intravenous cyclophosphamide 
500 mg in addition to her ongoing therapy. Three days later, the 
patient still had dyspnea with increased heart rate (130 times/ 
minute) and respiration rate (39 times/ minute). Her blood 
gas analysis showed severe hypoxia  with type I respiratory 
failure. There was no chance for assisted ventilation as she 
suddenly had cardiac arrest and died. 
Her baby had neonatal jaundice and sepsis after about 
1.5 month in incubator, but with proper treatment he was 
fi nally discharged from the hospital without any episode of 
hypothyroidism.
DISCUSSION
Scleroderma is a connective tissue disease of unknown etiology 
that affl icts the lungs, heart, gastrointestinal tract, and kidneys. 
It is a relatively rare disease with an estimated incidence rate 
ranging from 2 to 10 cases per million. The etiopathogenesis 
of scleroderma includes vascular dysfunction, mononuclear 
mediated infl ammation, and connective tissue fi brosis.2 
Examination for thyroid dysfunction is important in 
scleroderma as many symptoms of hypothyroidism and 
hyperthyroidism overlap with scleroderma features. Thyroid 
fi brosis, autoimmune thyroiditis resulting in hypothyroidism, 
and hyperthyroidism from Graves’ disease are frequent and 
often unsuspected in scleroderma. Fibrosis of the thyroid 
gland may develop in the presence or absence of autoimmune 
thyroiditis. In a Hungarian population, the prevalence of 
Hashimoto’s thyroiditis and Graves’ disease was 220-fold 
higher and 102-fold higher, respectively, in scleroderma 
patients than in the general population. In particular, anti-
thyroid peroxidase (anti-TPO) antibodies are more commonly 
observed in scleroderma than in controls, and it has been 
suggested that anti-TPO antibodies may identify the subset of 
patients at risk for subsequent thyroid dysfunction. It suggests 
that assessment of thyroid function and anti-TPO antibodies 
should be done in routine clinical evaluations of patients with 
scleroderma.3,4 In this case, the cause of  hyperthyroidism 
was possibly Grave’s disease, because thyroid gland fi brosis 
usually manifests as hypothyroidism. However, there was no 
examination of thyroid antibodies due to lack of reagent in 
the hospital. With anti-thyroid drug (propylthiouracil), she 
became euthyroid.
Effects of scleroderma on women fertility
The patient had been married for fi ve years without any 
history of pregnancy and contraception (primary infertility). 
Her irregular menstrual period could be due to the SSc itself 
or her hyperthyroidism. The issue of fertility in women with 
SSc is also diffi cult to determine because there are many 
factors, both physical and psychological, affecting pregnancy. 
Reduced self esteem and altered body image may have great 
Picture 4 No abnormality detected in the Chest X-Ray
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impact to the ability of patients with scleroderma to form 
social and sexual relationships. The disease poses further 
diffi culties to interpersonal relationships due to vaginal 
dryness and dyspareunia which affl icts up to 37% of patients, 
as well as arthritic involvement and joint contractures which 
may prevent sexual intercourse. However, there were no 
specifi c fi ndings causing infertility that could be attributed 
specifi cally to SSc.2,5
Women with scleroderma have twice the rate of 
spontaneous abortion and three times the rate of infertility 
(no successful pregnancy up to the age of 35) compared with 
normal women. The overall rate of a successful pregnancy 
following a period of infertility was 37% in the scleroderma 
patients, similar to the 40% rate in RA patients and 43% in 
normal controls.2
Effects of scleroderma and hyperthyroidism on pregnancy
The reported outcomes of pregnancy in women with SSc were 
quite variable. Early literatures were fi lled with case reports 
of SSc on pregnancy that resulted in unfavorable outcomes to 
the mother and/or the baby.5 But nowadays close monitoring 
and appropriate therapy helped scleroderma patients to have a 
successful pregnancy. In this patient, there were some obstetric 
complications such as IUGR, premature labor, and the need of 
emergency caesarean section.6,7 As seen in table 1, those three 
are the most frequent obstetric complications in SSc patients. 
Table 1 Pregnancy complications in SSc compared with GOP6
SSc n(%) GOP* n(%) P (SSc vs GOP)
Deliveries, n° 106 3939
Intrauterine growth restriction (IUGR) (<5th 
percentile)
6 (6%) 58 (1%) p=0,005
Preterm premature rupture of membrane 7 (7%) 126 (3%) NS
Preterm deliveries <37 weeks 32 (30%) 470 (12%) p<0,001
Cesarean section 54 (51%) 1222 (31%) p<0,001
Gestational hypertension 1 (1%) 123 (3%) NS
Pre-eclampsia/HELLP 1 (1%) 43 (1%) NS
Eclampsia 0 (0%) 0 (0%) NS
*GOP: Data from General Obstetric Population followed in 2009 in one of the referral centers
Patients with diffuse skin involvement suffered from more 
signifi cant morbidities, with premature delivery dominating 
40% of pregnancies. Despite all of the possible complications, 
the overall rate of successful delivery was 84% in limited and 
77% in diffuse scleroderma.2
A study for over 12 years involving 60 cases of 
hyperthyroidism on pregnancy in University Hospital of Wales 
UK found that metabolic status at delivery correlated with 
pregnancy outcome. Preterm delivery, perinatal mortality, 
and maternal heart failure were more common in women who 
remained thyrotoxic even with clear diagnosis and treatment.8 
In this patient, she already had hyperthyroidism before her 
pregnancy and anti-thyroid therapy (PTU) was continued 
during pregnancy.
Effects of pregnancy on scleroderma and hyperthyroid
In pregnancy, there is an increase of T helper-2, which allows 
a woman’s body to tolerate the fetus, and this is thought to 
be the reason why the severity of Graves’ hyperthyroidism 
(and other autoimmune diseases) usually lessens after the fi rst 
trimester 9. On rare occasions, labour, caesarean section, and 
infections may aggravate hyperthyroidism into thyroid storm. 
Most pregnant women with hyperthyroidism have already 
been diagnosed prior to pregnancy and they tolerate mild to 
moderate degrees of hyperthyroidism relatively well. Graves 
may be exacerbated in the early parts of pregnancy, but as 
immune suppression typically occurs with the pregnancy, the 
disease becomes less active. After delivery, they may remain 
in permanent remission, but recurrence is also possible.8,10 In 
this patient, there was an impending thyroid crisis that could be 
induced by infection (pneumonia), but she became euthyroid 
at the end period of pregnancy by using propylthiouracil 100 
mg t.i.d. and there was no episode of recurrence postpartum.
Pregnancy appears to exacerbate organs involvement 
or adversely affect 10 year survival of scleroderma patients. 
In a prospective series, maternal disease was stable in 
60% of cases, improved in 20%, and worsened in another 
20%. However, the enlarging gravid uterus may worsen 
gastroesophageal refl ux, which is a prevalent symptom in 
scleroderma. Likewise, limitation of diaphragmatic breathing 
may exacerbate pre-pregnancy dyspnea.. On the other hand, 
Raynaud’s phenomenon tends to improve in pregnancy due to 
generalized peripheral vasodilation. Even though pregnancy 
is not considered to worsen skin disease, progressive skin 
thickening has been observed in the postpartum women with 
diffuse disease. As women with diffuse scleroderma are at 
greater risks for early cardiopulmonary and renal problems, 
they need to delay pregnancy until their organ functions are 
stable.2 Generally, effects of pregnancy on scleroderma can be 
seen in table 2 below.5
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Table 2 Effects of pregnancy on systemic sclerosis










Improved during pregnancy, worsen after/
during complicated deliveries
possibility of onset during pregnancy and 
progressive involvement in postpartum with 
diffuse SSc 
arthralgia, similar to pregnant women without 
scleroderma 
reflux, similar to pregnant women without 
scleroderma
Worsening shortness of breath and should 
be managed as in any pregnancy with 
compromised cardiopulmonary status
Renal crisis occurs during early diffuse 
scleroderma with or without pregnancy. Should 
be managed with ACE-inhibitors despite the 
fetal risks
 
Pregnant women with scleroderma are at high risks 
because of their possibility of having premature delivery and 
other maternal complications, most notably scleroderma renal 
crisis (SRC). Initial risk assessment should include disease 
grading, as women with diffuse disease are at higher risk for 
miscarriage, preterm delivery, and SRC.2 
Management of scleroderma and hyperthyroidism in 
pregnancy
Management of scleroderma patients during pregnancy, labor, 
and delivery can be seen in the table 3 below.5
Table 3 Management of scleroderma patients during pregnancy, 
labor, and delivery5
Preterm
1. Early evaluation of the extent of organ involvement and autoantibody 
analysis, including echocardiogram and pulmonary function if 
necessary
2. Discontinue the use of disease-remitting drugs with teratogenic 
potential (i.e., MMF, methotrexate, etc.) before pregnancy
3. High-risk obstetric care
4. Reassurance to the mother 
5. Minimal use of proton pump inhibitors, histamine antagonist, or 
calcium-channel blockers for gastrointestinal and vascular problems 
6. Avoidance of corticosteroids
7. frequent monitoring of fetal size and uterine activity
8. Frequent blood pressure monitoring
9. Aggressive treatment of hypertension 
10. Close observation and treatment for premature labor (avoid beta-
adrenergic agonists)
Labor and delivery
1. Epidural anesthesia is preferred
2. Warming of delivery room, intravenous fluid, and the patients 
themselves (e.g., extra blankets, thermal socks, gloves)
3. Venous access before delivery
4. Careful attention to the episiotomy and incisions, which generally 
heal without difficulty
Post delivery
1. Continue careful monitoring postpartum, with early reinstitution of 
medication and aggressive treatment of hypertension
There is no data regarding the preferred method of 
delivery in scleroderma patients and the decision should be 
made based on a joint consultation of the inter-disciplinary 
team. When there is no fetal distress, pulmonary, cardiac, or 
renal involvement and the patients have good range of motion 
of hip joints, vaginal delivery is the better choice. One should 
also keep in mind that severe restrictive lung disease may exist 
in patients without alveolitis due to established lung fi brosis 
as well as chest-wall involvement. Performing pulmonary 
function tests during the fi rst trimester, and if needed, repeating 
them in later stages of pregnancy, is advisable. The presence of 
major organ involvement or severe musculoskeletal restriction 
may emerge the need to have cesarean section.2 In this case; 
the indication of cesarean section was fetal distress. 
When organs are severely damaged, such as in cases of 
severe cardiomyopathy (ejection fraction <30%), pulmonary 
hypertension, severe restrictive lung disease (forced vital 
capacity <50%), malabsorption, or renal insuffi ciency, the 
decision to terminate the pregnancy may have to be considered 
depending on the risks to the mother and the fetus.5 In this 
case, her heart and kidney were normal and there was no 
sign of scleroderma renal crisis. Unfortunately, there was no 
chance to perform chest HRCT and pulmonary function test. 
The dyspnea worsened 10 days after delivery and she had 
been given intravenous cyclophosphamide, but it did not help 
(maybe too late), she got respiratory failure and died. 
Interstitial lung disease (ILD) is a common manifestation 
of SSc and mainly encountered in patients with diffuse disease 
and/or anti-topoisomerase 1 antibodies. ILD is now the 
major cause of mortality in patients with SSC after dramatic 
reduction in death caused by scleroderma renal crisis, because 
of the regular use of ACE inhibitors. Although it is important 
to treat ILD in SSc early, but progression of lung involvement 
may be variable and diffi cult to predict. ILD develops in up to 
75% of patients with SSc overall. However, SSc-ILD evolves 
to end-stage respiratory insuffi ciency in only a few patients. 
Initial pulmonary function tests (PFT) with measurement of 
carbon monoxide diffusing capacity, together with HRCT, 
allows for early diagnosis of SSc-ILD, before the occurrence 
of dyspnea.11,12 This patient had a diffuse disease and her anti-
topoisomerase 1 antibodies (Anti-Scl-70) was also positive, 
making her prone to have ILD. The progress of the ILD 
was quite fast. In a week she had become worse, fell into 
respiratory failure despite of intravenous cyclophosphamide.
SUMMARY
This is a case report about a pregnant woman with scleroderma 
and hyperthyroidism. There were some obstetric complications 
such as IUGR, premature labor, and the need of emergency 
cesarean section, but the pregnancy was ended successfully. 
Unfortunately 10 days after delivery she was admitted again 
into the hospital due to rapid progressive ILD. Although 
intravenous cyclophosphamide had been administered, she 
fell into respiratory failure and died. After about 1.5 month 
of care in NICU due to low body weight, neonatal jaundice, 
and sepsis, the baby was discharged without signifi cant 
abnormality.
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